Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy?

被引：18
|
作者：
Piantanida, E. [1 ]
Bartalena, L. [1 ]
机构：
[1] Univ Insubria, Endocrine Unit, Dept Med & Surg, Osped Circolo,ASST Sette Laghi, Viale Borri 57, Varese, Italy
来源：
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 2017年 / 40卷 / 08期
关键词：
RITUXIMAB; DISEASE; OPHTHALMOPATHY; EFFICACY; THERAPY;
D O I：
10.1007/s40618-017-0717-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：885 / 887
页数：3
相关论文
共 50 条
  • [1] Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves’ orbitopathy?
    E. Piantanida
    L. Bartalena
    Journal of Endocrinological Investigation, 2017, 40 : 885 - 887
  • [2] Role of teprotumumab in the treatment of active moderate-to-severe Graves' orbitopathy
    Bartalena, Luigi
    EUROPEAN THYROID JOURNAL, 2022, 11 (06)
  • [3] What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
    Bartalena, Luigi
    CLINICAL ENDOCRINOLOGY, 2010, 73 (02) : 149 - 152
  • [4] Is Radioactive Iodine Contraindicated in Patients with Moderate-to-Severe and Active Graves' Orbitopathy?
    Bartalena, Luigi
    Tanda, Maria Laura
    THYROID, 2025,
  • [5] Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy
    Lin, Miaoli
    Mao, Yuxiang
    Ai, Siming
    Liu, Guangming
    Zhang, Jian
    Yan, Jianhua
    Yang, Huasheng
    Li, Aimin
    Zou, Yusha
    Liang, Dan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [6] Misfortunes do not come in pairs in patients with active moderate-to-severe Graves' orbitopathy
    Sawicka-Gutaj, Nadia
    Gruszczynski, Dawid
    Zawalna, Natalia
    Nijakowski, Kacper
    Fichna, Marta
    Ruchala, Marek
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (06):
  • [7] Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy
    Marcocci, Claudio
    Marino, Michele
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 26 (03) : 325 - 337
  • [8] Proposal for Standardization of Primary and Secondary Outcomes in Patients with Active, Moderate-to-Severe Graves' Orbitopathy
    Bartalena, Luigi
    Wiersinga, Wilmar M.
    EUROPEAN THYROID JOURNAL, 2020, 9 (SUPPL 1) : 3 - 16
  • [9] Treatment of moderate-to-severe and active Graves' orbitopathy: a step forward from the OPTIC study
    Tanda, M. L.
    Gallo, D.
    Ippolito, S.
    Bartalena, L.
    Piantanida, E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (10) : 1523 - 1525
  • [10] Treatment of moderate-to-severe and active Graves’ orbitopathy: a step forward from the OPTIC study
    M. L. Tanda
    D. Gallo
    S. Ippolito
    L. Bartalena
    E. Piantanida
    Journal of Endocrinological Investigation, 2020, 43 : 1523 - 1525
12345